circRNA basic information
circBase ID: hsa_circ_0058608
Name: hsa_circ_SP140L
Synonym: circ_0058608
Host Gene: -
Genomic location(hg19): chr2:231264841-231266522:+
Genomic location(hg38): chr2:230400126-230401807:+
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0005233
MONDO name: non-small cell lung carcinoma
Disease details: non-small cell lung cancer / NSCLC
Disease DO ID:
3908
Disease MeSH ID:
D002289
Disease NCIt ID:
C2926
Disease ICD11 ID:
-
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

NSCLC tissue specimens; corresponding normal tissue specimens; tumor tissues

Cell lines:

BEAS-2B; A549; H1299; A549/taxol; H1299/taxol

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: GBP1, Ago2
Associated microRNA: miR-1299
Biological function: promotes NSCLC cell proliferation, migration, invasion, EMT, tumor growth and taxol resistance; inhibits taxol-induced apoptosis
Molecular mechanism: circ_0058608 acts as a miR-1299 sponge to positively regulate GBP1 expression, thereby promoting NSCLC progression and taxol resistance
Biological pathway or process:

proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); EMT (promotes); apoptosis (inhibits); ceRNA regulation (promotes); drug resistance (promotes); chemoresistance (promotes)

Detected method:
Q
Validation methods:

RT-qPCR; Clinical Sample Validation; Transfection; EdU Staining; Colony Formation Assay; Transwell Assay; Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry); CCK8; Annexin V/PI Flow Cytometry; Bioinformatics Analysis; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); Survival Analysis

Clinical significance:

high circ_0058608 expression is associated with poor survival in NSCLC patients and circ_0058608 siRNA might be a possible therapeutic approach for NSCLC tumorigenesis and drug resistance

Description:

circ_0058608 is up-regulated in NSCLC and further elevated in taxol-resistant NSCLC tissues and cells. It promotes NSCLC proliferation, migration, invasion, EMT, tumor growth, and taxol resistance by sponging miR-1299 and upregulating GBP1; high expression is associated with poor patient survival.

Confidence score:

0.7794

Other information
Title:

Circ_0058608 contributes to the progression and taxol resistance of non-small cell lung cancer by sponging miR-1299 to upregulate GBP1.

Journal: Anti-cancer drugs
Published: 2023
PubMed ID: 36539364
Study type:

combined biological and clinical study

Data availability: Supplemental digital content 1, http://links.lww.com/ACD/A443; Please contact the corresponding author for the data request.
Code availability: -